SAT0068 The time until performing tight control as a treat-to-target strategy and the tolerability of methotrexate strongly influence the achievement of clinical remission in rheumatoid arthritis

Abstract

BackgroundClinical remission (CR) is the first targeted outcome of early treatment for rheumatoid arthritis (RA). Therefore, a consensus is needed for achieving CR by using the treat-to-target (T2T) strategy in...